Edition:
United States

Aevi Genomic Medicine Inc (GNMX.OQ)

GNMX.OQ on NASDAQ Stock Exchange Global Market

2.00USD
12:54pm EST
Change (% chg)

$0.05 (+2.56%)
Prev Close
$1.95
Open
$1.89
Day's High
$2.08
Day's Low
$1.86
Volume
40,156
Avg. Vol
71,023
52-wk High
$6.17
52-wk Low
$0.98

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.232
Jun '17 0.00 -0.216
Mar '17 0.00 -0.294
FY 2016 Dec '16 0.00 -0.229
Sep '16 0.00 -0.285
Jun '16 0.00 -0.350
Mar '16 0.00 -0.338
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 3 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Mar-18 2 -0.15 -0.14 -0.16 -0.44
Quarter Ending Jun-18 2 -0.17 -0.17 -0.18 -0.48
Year Ending Dec-18 3 -0.66 -0.63 -0.68 -1.26
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 192.73 34.59
P/E High - Last 5 Yrs. -- 285.47 45.93
P/E Low - Last 5 Yrs. -- 93.40 24.19
Beta 1.05 0.81 0.81
Price to Sales (TTM) -- 137.31 8.08
Price to Book (MRQ) 7.17 20.28 5.24
Price to Tangible Book (MRQ) 11.46 27.91 6.43
Price to Cash Flow (TTM) -- 126.48 25.98
% Owned Institutions 20.67 11.77 2.27

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.52
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.87 5.21
Payout Ratio(TTM) -- 8.18 43.34

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 65.12 9.76
Sales (TTM) vs TTM 1 Yr. Ago -- 62.55 7.61
Sales - 5 Yr. Growth Rate -- 33.48 10.20
EPS (MRQ) vs Qtr. 1 Yr. Ago 18.65 -97.40 18.78
EPS (TTM) vs TTM 1 Yr. Ago 17.18 -- --
EPS - 5 Yr. Growth Rate -- 46.98 11.55
Capital Spending - 5 Yr. Growth Rate -5.22 43.68 14.73

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.42
Current Ratio (MRQ) 2.32 6.12 3.39
LT Debt to Equity (MRQ) 0.00 16.26 12.18
Total Debt to Equity (MRQ) 0.00 18.35 15.60
Interest Coverage (TTM) -1,475.37 -160.93 38.48

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 46.39 54.74
Gross Margin - 5 Yr. Avg. -- 55.21 52.50
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -233.45 14.67
Operating Margin (TTM) -- -490.18 4.40
Operating Margin - 5 Yr. Avg. -- -250.27 9.99
Pre-Tax Margin (TTM) -- -465.60 5.14
Pre-Tax Margin - 5 Yr. Avg. -- -256.86 10.24
Net Profit Margin (TTM) -- -447.98 1.86
Net Profit Margin - 5 Yr. Avg. -- -260.25 6.55
Effective Tax Rate (TTM) -- 0.27 21.87
Effective Tax Rate - 5 Yr. Avg. -- 17.76 24.11

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,887,942 823,803,020
Net Income/Employee (TTM) -1,501,583 -537,326 96,327,335
Receivable Turnover (TTM) -- 14.02 5.44
Inventory Turnover (TTM) -- 2.38 3.52
Asset Turnover (TTM) 0.00 0.39 0.91

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -110.41 -1.02 10.76
Return on Assets - 5 Yr. Avg. -91.25 -0.09 12.05
Return on Investment (TTM) -136.18 -0.67 13.67
Return on Investment - 5 Yr. Avg. -103.34 2.39 15.78
Return on Equity (TTM) -136.18 -3.38 15.40
Return on Equity - 5 Yr. Avg. -109.36 -1.61 17.04
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 15.98 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aevi Genomic Medicine Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 20.67%
# of Holders: 59
Total Shares Held: 12,266,721
3 Mo. Net Change: 2,193,144
# New Positions: 6
# Closed Positions: 10
# Increased Positions: 15
# Reduced Positions: 23
# Net Buyers: -8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.